Why carry out this study?

This study investigated the inflammatory response following cataract surgery in patients with Fuchs’ endothelial corneal dystrophy (FECD), a condition that complicates surgical outcomes.

The study aimed to provide recommendations for the optimal timing of Descemet membrane endothelial keratoplasty (DMEK) surgery in patients with FECD.

What was learned from the study?

The study found that alterations in proinflammatory cytokines might be the underlying cause of persistent anterior chamber (AC) inflammation after cataract surgery.

These findings suggest that either combining cataract surgery with DMEK in phakic FECD patients or extending the interval between the two procedures may offer greater benefits by potentially enhancing patient outcomes and minimizing postoperative inflammation.